5.3 Hypertension Management, Hypertensive Emergencies & Stroke Care

5.3 Hypertension Management, Hypertensive Emergencies & Stroke Care

Quick Answer: Systemic hypertension is a major cardiovascular threat and leading cause of stroke, renal failure, and heart failure in Ghana, requiring structured staging, lifestyle interventions, and evidence-based pharmacotherapy using thiazides, calcium channel blockers, ACE inhibitors, or ARBs. A critical clinical distinction must be drawn between Hypertensive Urgency (severe BP >= 180/120 mmHg without acute target organ damage, managed with oral medications over 24-48 hours) and Hypertensive Emergency (severe BP >= 180/120 mmHg accompanied by acute end-organ damage, requiring controlled IV antihypertensive titration to reduce mean arterial pressure by no more than 20-25% in the first hour). In acute stroke care, nurses rapidly identify neurological deficits using the FAST screening tool and NIHSS, obtain emergent non-contrast brain CT scans, protect the ischemic penumbra by maintaining head-of-bed elevation at 30 degrees, observe strict blood pressure parameters for IV alteplase thrombolysis within the 4.5-hour therapeutic window, and enforce rigorous bedside water swallow screening before oral administration to prevent aspiration pneumonia.

---

Hypertension: Definition, Staging, and Public Health Impact in Ghana

Systemic arterial hypertension is defined as a sustained elevation of systemic blood pressure with a systolic blood pressure (SBP) >= 140 mmHg or a diastolic blood pressure (DBP) >= 90 mmHg, confirmed on two or more separate clinical encounters under standardized resting conditions.

Population surveys in Ghana commonly report hypertension in roughly one in four to one in three adults, and many people with raised blood pressure do not know it. Known clinically as the "silent killer," hypertension is often asymptomatic until target-organ injury occurs, and it is a leading risk factor for stroke, heart failure and chronic kidney disease.

Clinical Staging Framework

Etiological Classification: Primary vs. Secondary Hypertension

• Essential (Primary) Hypertension (90% – 95% of cases): No single identifiable organic etiology; results from a complex interplay of genetic predisposition, neurohormonal dysregulation (excessive sympathetic activity, hyperactive RAAS), endothelial dysfunction, obesity, high dietary sodium intake, chronic psychological stress, and advancing age.
• Secondary Hypertension (5% – 10% of cases): Elevated blood pressure attributable to an identifiable, often surgically or medically treatable underlying organic disorder:
  • Renal: Renal artery stenosis (renovascular hypertension), chronic glomerulonephritis, polycystic kidney disease;
  • Endocrine: Primary aldosteronism (Conn syndrome), Pheochromocytoma (catecholamine-secreting adrenal medullary tumor presenting with paroxysmal headache, sweating, and palpitations), Cushing syndrome, hyperthyroidism;
  • Vascular / Other: Coarctation of the aorta (differential blood pressure with high readings in upper limbs and weak/delayed femoral pulses in lower limbs), obstructive sleep apnea (OSA), oral contraceptive use.

Target End-Organ Damage

Chronic untreated hypertension damages vascular endothelial beds throughout the body, producing target-organ damage (TOD):

• Heart: Concentric left ventricular hypertrophy (LVH), coronary artery disease, angina, myocardial infarction, and congestive heart failure;
• Brain: Ischemic stroke, intracerebral hemorrhage, transient ischemic attack (TIA), and hypertensive encephalopathy;
• Kidneys: Hypertensive nephrosclerosis, microalbuminuria, proteinuria, and progressive chronic kidney disease leading to dialysis dependency;
• Retina (Hypertensive Retinopathy): Arteriolar narrowing ("copper-wiring" and "silver-wiring"), arteriovenous nicking, flame-shaped retinal hemorrhages, cotton-wool spots (microinfarcts), and papilledema (optic disc swelling indicating malignant hypertension).

---

Pharmacological Management of Hypertension

Clinical guidelines in Ghana and international consensus (such as the International Society of Hypertension and WHO) emphasize specific drug classes for managing hypertension, particularly accounting for African ancestry where low-renin hypertension predominates.

+---------------------------------------------------------------------------------+
|                       FIRST-LINE ANTIHYPERTENSIVE CLASSES                       |
+---------------------------------------------------------------------------------+
| 1. Calcium Channel Blockers (CCBs - Dihydropyridines):                          |
|    - Agents: Amlodipine (5-10 mg daily), Nifedipine retard (20-60 mg daily).    |
|    - Mechanism: Inhibits L-type calcium channels -> potent arterial vasodilation|
|    - **First-line choice for Black African individuals**; reduces stroke risk.  |
|    - Side effects: Peripheral ankle edema, headache, flushing, dizziness.       |
|                                                                                 |
| 2. Thiazide & Thiazide-Like Diuretics:                                          |
|    - Agents: Hydrochlorothiazide (12.5-25 mg daily), Chlorthalidone, Indapamide.|
|    - Mechanism: Inhibits Na+/Cl- cotransporter in distal convoluted tubule.     |
|    - **Highly effective in Black African patients** (salt-sensitive profiles).  |
|    - Side effects: Hypokalemia, hyponatremia, hyperuricemia (gout), hyperglycemia|
|                                                                                 |
| 3. Angiotensin-Converting Enzyme (ACE) Inhibitors:                              |
|    - Agents: Lisinopril (10-40 mg daily), Enalapril, Ramipril, Captopril.       |
|    - Mechanism: Blocks conversion of Angiotensin I to Angiotensin II.           |
|    - Renal and cardiac protective (first-line in diabetes with proteinuria).    |
|    - Side effects: **Dry, hacking cough** (due to bradykinin accumulation),     |
|      **Hyperkalemia**, and **Angioedema** (life-threatening swelling;           |
|      3-4 times higher incidence in patients of African ancestry!).              |
|    - Contraindicated in pregnancy (teratogenic) and bilateral renal artery sten.|
|                                                                                 |
| 4. Angiotensin Receptor Blockers (ARBs):                                        |
|    - Agents: Losartan (50-100 mg daily), Telmisartan, Valsartan.                |
|    - Mechanism: Competitively blocks AT1 receptors; does NOT increase bradykinin|
|    - Preferred alternative when patients develop intolerable ACE inhibitor cough|
|    - Contraindicated in pregnancy; monitor for hyperkalemia.                    |
+---------------------------------------------------------------------------------+

---

Hypertensive Crisis: Urgency vs. Emergency

A hypertensive crisis is defined as an acute, severe elevation in blood pressure, typically with a systolic BP >= 180 mmHg and/or diastolic BP >= 120 mmHg. The clinical management hinges entirely upon the presence or absence of acute, progressing target-organ damage.

                            HYPERTENSIVE CRISIS
                       (BP >= 180 and/or >= 120 mmHg)
                                     |
                    +----------------+----------------+
                    |                                 |
          NO ACUTE ORGAN DAMAGE              ACUTE ORGAN DAMAGE PRESENT
                    |                                 |
                    v                                 v
           HYPERTENSIVE URGENCY             HYPERTENSIVE EMERGENCY
           - Headache, epistaxis             - Encephalopathy, stroke
           - Oral medications                - Acute pulmonary edema, ACS
           - Lower over 24 to 48 hours       - Aortic dissection, eclampsia
           - Outpatient / short-stay         - ICU admission, continuous IV
                                             - Lower MAP max 20-25% in 1st hr

Clinical Comparison and Management Protocols

• Hypertensive Urgency:
  • Severe blood pressure elevation WITHOUT acute, life-threatening target-organ damage;
  • Patients may present with mild headache, epistaxis, or moderate anxiety, but physical examination reveals no acute heart failure, neurological deficit, or retinal papilledema;
  • Management: Treated with oral antihypertensive agents (e.g., oral amlodipine, captopril, labetalol, or clonidine). The goal is gradual blood pressure reduction over 24 to 48 hours. Rapid or aggressive intravenous reduction is contraindicated, as it may precipitate cerebral or myocardial hypoperfusion.
• Hypertensive Emergency:
  • Severe blood pressure elevation ACCOMPANIED BY acute, progressive, life-threatening target-organ damage;
  • Clinical Manifestations:
    • Hypertensive Encephalopathy: Severe headache, confusion, somnolence, seizures, visual loss, or coma;
    • Cardiovascular: Acute pulmonary edema with respiratory distress and pink frothy sputum; Acute coronary syndrome / MI; Acute aortic dissection (severe, tearing chest or interscapular back pain with blood pressure asymmetry between arms);
    • Renal: Acute renal failure with oliguria, hematuria, and azotemia;
    • Obstetric: Severe pre-eclampsia or eclampsia (convulsions in pregnant women);
  • Management: Requires immediate admission to an Intensive Care Unit (ICU) or high-dependency resuscitation bay for continuous intra-arterial blood pressure monitoring and titratable intravenous antihypertensives (e.g., IV Labetalol, Hydralazine, Nicardipine, or Sodium Nitroprusside).

[!CAUTION] The Safe Lowering Rule: Mean Arterial Pressure (MAP) In hypertensive emergencies (with the sole exception of acute aortic dissection), do NOT precipitously normalize blood pressure to 120/80 mmHg. Chronic hypertension shifts the brain's autoregulatory curve to the right. Rapid normalization drops cerebral perfusion pressure below the autoregulatory threshold, inducing cerebral ischemia and watershed infarction.

• First Hour Goal: Lower Mean Arterial Pressure (MAP) by no more than 20% to 25%;
• Next 2 to 6 Hours: If stable, lower toward 160/100–110 mmHg;
• Next 24 to 48 Hours: Gradually achieve normal baseline pressure;
• Formula for MAP: $\text{MAP} = \frac{\text{Systolic BP} + 2(\text{Diastolic BP})}{3}$
• Exception: In Acute Aortic Dissection, blood pressure must be dropped rapidly within 20 minutes (target SBP < 120 mmHg and HR < 60 bpm) to reduce aortic wall shear stress.

---

Cerebrovascular Accident (CVA / Stroke)

A stroke (cerebrovascular accident) is an acute neurological deficit caused by focal vascular compromise of cerebral tissue lasting greater than 24 hours or resulting in acute infarction or hemorrhage on neuroimaging.

Etiological Types of Stroke

1. Ischemic Stroke (80% – 85% of cases): Results from arterial occlusion depriving brain parenchyma of oxygen and glucose:
   • Thrombotic Stroke: In situ clot formation over an atherosclerotic plaque within a cerebral artery (e.g., middle cerebral artery or internal carotid artery); often preceded by TIAs, frequently occurring during sleep or early morning;
   • Embolic Stroke: Clot fragments, vegetations, or debris traveling from a distant vascular source (most commonly cardiac origin due to Atrial Fibrillation, mural thrombus post-MI, or carotid artery plaque bifurcation) that lodge in a cerebral vessel; sudden, unheralded daytime onset.
2. Hemorrhagic Stroke (15% – 20% of cases): Results from vascular rupture with bleeding into cerebral tissue or surrounding meningeal spaces:
   • Intracerebral Hemorrhage (ICH): Rupture of small penetrating arteries (Charcot-Bouchard aneurysms) deep within the basal ganglia, thalamus, pons, or cerebellum, triggered by longstanding uncontrolled hypertension. Rapid expansion causes elevated intracranial pressure (ICP), headache, vomiting, and focal deficits;
   • Subarachnoid Hemorrhage (SAH): Extravasation of arterial blood into the subarachnoid space, classically caused by rupture of a saccular (berry) aneurysm at the circle of Willis or arteriovenous malformation (AVM). Hallmark symptom: Sudden, explosive, agonizing "thunderclap headache" (described by patients as the "worst headache of my life"), accompanied by meningismus (nuchal rigidity, photophobia, positive Kernig and Brudzinski signs), vomiting, and loss of consciousness.

Emergency Screening: The FAST Tool & NIHSS Basics

Rapid public and triage recognition of stroke symptoms utilizes the FAST mnemonic:

• F — Face Dropping: Does one side of the face droop or is the smile uneven?
• A — Arm Weakness: Can the patient raise both arms, or does one arm drift downward?
• S — Speech Difficulty: Is speech slurred, strange, or absent (expressive/receptive aphasia)?
• T — Time to Call: Emergency! Note the exact time last known normal and activate emergency care.

The National Institutes of Health Stroke Scale (NIHSS) is a standardized, quantitative 11-domain neurological evaluation assessing level of consciousness, gaze, visual fields, facial palsy, motor arm and leg function, limb ataxia, sensory loss, language/aphasia, dysarthria, and inattention (extinction). Scores range from 0 (normal) to 42 (severe stroke), guiding reperfusion decisions and prognostic recovery.

Emergency Diagnostic Imaging

An emergent non-contrast Computed Tomography (CT) scan of the brain must be performed immediately upon hospital arrival. Its paramount clinical objective is to rule out hemorrhage. An acute ischemic stroke may appear completely normal on CT during the initial 6 to 12 hours, but an acute hemorrhage appears immediately as a bright hyperdense (white) area. Thrombolysis is strictly contraindicated if intracranial hemorrhage is visualized.

---

Acute Stroke Nursing Management and Interventions

+--------------------------------------------------------------------------+
|                       ACUTE STROKE NURSING BUNDLE                        |
+--------------------------------------------------------------------------+
| 1. Airway & Position: Elevate Head of Bed (HOB) to 30 degrees; maintain |
|                       SpO2 >= 94%; avoid neck flexion to promote venous  |
|                       drainage and decrease intracranial pressure.       |
|                                                                          |
| 2. Blood Pressure:    - Candidate for IV rtPA: Maintain < 185/110 mmHg.  |
|                       - Non-thrombolytic: Permissive hypertension up to   |
|                         220/120 mmHg to preserve penumbral perfusion.    |
|                                                                          |
| 3. Glucose & Temp:    Maintain glucose 7.8-10.0 mmol/L (avoid hypoglycemia|
|                       which mimics stroke; treat fever > 37.5°C).        |
|                                                                          |
| 4. Dysphagia Screen:  STRICT NPO STATUS until bedside water swallow test |
|                       is passed; prevents fatal aspiration pneumonia.    |
|                                                                          |
| 5. DVT Prophylaxis:   Intermittent pneumatic compression (IPC) sleeves;  |
|                       low-dose heparin delayed 24 hours post-rtPA.       |
+--------------------------------------------------------------------------+

Detailed Clinical Nursing Protocols

1. Reperfusion Windows: For eligible ischemic stroke patients, intravenous Alteplase (recombinant tissue plasminogen activator / rtPA) at 0.9 mg/kg (maximum 90 mg; 10% bolus over 1 minute, 90% infused over 60 minutes) must be administered within a strict window of < 4.5 hours from time last known well. Mechanical endovascular thrombectomy is indicated for selected large-vessel occlusions, usually within 6 hours and in carefully selected patients up to 24 hours;
2. Blood Pressure Parameters:
   • For Thrombolytic Candidates: Blood pressure must be reduced to < 185/110 mmHg before starting rtPA, and maintained < 180/105 mmHg for at least 24 hours post-infusion to prevent fatal secondary hemorrhagic transformation;
   • For Non-Thrombolytic Patients: Permissive hypertension is maintained. Do NOT treat blood pressure unless SBP exceeds 220 mmHg or DBP exceeds 120 mmHg. Elevated systemic pressure is a vital compensatory mechanism that forces collateral blood flow into the ischemic penumbra (the salvageable, under-perfused brain tissue surrounding the dead infarct core);
3. Strict Aspiration Precautions & Bedside Swallow Screening: More than 50% of acute stroke patients experience acute oropharyngeal dysphagia. All stroke patients must be placed on strict NPO (nil per os) status—including oral medications, water, and food—until a validated bedside water swallowing test is conducted by a trained nurse with the patient seated upright at 90 degrees. If the patient exhibits coughing, throat clearing, wet voice quality, or delayed swallow reflex, oral intake is prohibited, and early fine-bore enteral feeding (nasogastric tube) is coordinated;
4. Glycemic and Thermal Control: Avoid hypoglycemia (< 3.9 mmol/L or < 70 mg/dL), which directly mimics focal neurological stroke deficits; manage hyperglycemia targeting blood glucose between 7.8 and 10.0 mmol/L (140 to 180 mg/dL) using subcutaneous regular insulin. Aggressively treat fever (core temperature > 37.5°C) with antipyretics and cooling measures, as hyperthermia accelerates cerebral metabolic rate and worsens neuronal necrosis;
5. Neurological Surveillance: Monitor for signs of deteriorating neurological status and elevated Intracranial Pressure (ICP) using the Glasgow Coma Scale and Cushing's Triad (profound bradycardia, irregular bradypneic respirations, and widening pulse pressure with severe systolic hypertension);
6. Complication Prevention & Rehabilitation: Apply intermittent pneumatic compression (IPC) devices to prevent Deep Vein Thrombosis (pharmacological anticoagulation is held for 24 hours following rtPA); turn the patient every 2 hours to prevent pressure injury; support paretic limbs with pillows to avoid subluxation; and engage multidisciplinary physiotherapy and occupational therapy within 24 to 48 hours for early functional motor rehabilitation.